Characterization of pazopanib resistance in renal cell carcinoma cell lines

被引：1
|
作者：
Vynnytska-Myronovska, Bozhena [1 ]
Heinzelmann, Joana [1 ]
Hoelters, Sebastian [1 ]
Stoeckle, Michael [1 ]
Junker, Kerstin [1 ]
机构：
[1] Saarland Univ, Homburg, Germany
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-2840
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2840
引用
收藏
页数：2
相关论文
共 50 条
  • [11] IDENTIFICATION AND CHARACTERIZATION OF CANCER STEM CELL OF RENAL CELL CARCINOMA CELL LINES
    Ueda, Kosuke
    Ogasawara, Sachiko
    Akiba, Jun
    Nakayama, Masamichi
    Sanada, Sakiko
    Suekane, Shigetaka
    Noguchi, Masanori
    Matsuoka, Kei
    Yano, Hirohisa
    JOURNAL OF UROLOGY, 2013, 189 (04): : E121 - E121
  • [12] Establishment and characterization of seven human renal cell carcinoma cell lines
    Shin, KH
    Ku, JL
    Kim, WH
    Lee, SE
    Lee, C
    Kim, SW
    Park, JG
    BJU INTERNATIONAL, 2000, 85 (01) : 130 - 137
  • [13] Chromophilic renal cell carcinoma: Characterization of four permanent cell lines
    Ramp, U
    Hildebrandt, B
    Moll, R
    Jaquet, K
    Gabbert, HE
    Gerharz, CD
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 175 - 175
  • [14] PAZOPANIB FOR THE TREATMENT OF RENAL CELL CARCINOMA AND OTHER MALIGNANCIES
    Sonpavde, Guru
    Hutson, Thomas E.
    Sternberg, Cora N.
    DRUGS OF TODAY, 2009, 45 (09) : 651 - 661
  • [15] Pazopanib for the Treatment of Patients with Advanced Renal Cell Carcinoma
    Lang, Joshua M.
    Harrison, Michael R.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2010, 4 : 95 - 105
  • [16] Effectiveness of pazopanib and SBRT in metastatic renal cell carcinoma
    Cihan, Yasemin Benderli
    WORLD JOURNAL OF UROLOGY, 2018, 36 (11) : 1797 - 1798
  • [17] Benefits of pazopanib over sunitinib for renal cell carcinoma
    Granovetter, Michael
    LANCET ONCOLOGY, 2016, 17 (03): : E93 - E93
  • [18] Effectiveness of pazopanib and SBRT in metastatic renal cell carcinoma
    Yasemin Benderli Cihan
    World Journal of Urology, 2018, 36 : 1797 - 1798
  • [19] Pazopanib or sunitinib for metastatic renal-cell carcinoma?
    Bennet, Neil
    LANCET ONCOLOGY, 2013, 14 (11): : E442 - E442
  • [20] Safety and tolerability of pazopanib in the treatment of renal cell carcinoma
    Zivi, Andrea
    Cerbone, Linda
    Recine, Federica
    Sternberg, Cora N.
    EXPERT OPINION ON DRUG SAFETY, 2012, 11 (05) : 851 - 859
12345